• Home
  • About
  • Contact
  • Disclaimer

Indiana Intellectual Property Blog

~ Trademark and Copyright Law Updates in Indiana

Indiana Intellectual Property Blog

Category Archives: Litigation

Indiana Patent Litigation Update

26 Thursday Feb 2009

Posted by Kenan Farrell in Indiana, Litigation, Patent, Southern District of Indiana

≈ Leave a comment

Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2009)
On Feb. 24, 2009, the Federal Circuit affirmed a decision by the District Court for the Southern District of Indiana to extend the statutory 30-month stay under 21 U.S.C. § 355(j)(5)(B)(iii), thereby preventing the U.S. Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc.

See Patent Docs for the full case history and analysis.

Indiana Trademark Litigation Update – Boss Products v. Port-A-Pit Bar-B-Que of Edgerton

11 Wednesday Feb 2009

Posted by Kenan Farrell in Indiana, Litigation, Northern District of Indiana, Trademark

≈ Leave a comment

Tags

Robert L. Miller

Boss Products, Inc. v. Port-A-Pit Bar-B-Que of Edgerton, Inc.
No: 3:05-CV-293 RM (February 4, 2009)
U.S. District Court, N.D. of Indiana
Before: Chief Judge Miller

For full opinion:
2009 U.S.Dist.LEXIS 8192

TRADEMARKS; LACHES

Opinion (Miller): Plaintiff Boss Products sued defendant Port-A-Pit Bar-B-Que of Edgerton, Ohio (Edgerton) for infringement of registered trademark (PORT-A-PIT) after Edgerton conducted business under PORT-A-PIT for 30 years.  Defendant moved for summary judgment, arguing that Boss Products inexcusably delayed enforcement of its trademark rights and therefore its recovery should be barred under laches or acquiescence.  The record indicated that Boss Products had knowledge of Edgerton’s use of the mark from the beginning and the 30 years of extreme delay would cause substantial prejudice if Edgerton was forced to rebuild its business under a new name.  Edgerton’s motion for summary judgment was granted.

KLF Legal: Note that the PORT-A-PIT registration (abstract below) was assigned to Boss Products back in December ’04.  Apparently, Boss continued to be unhappy about Edgerton’s use of the mark.  Edgerton relied on the doctrine of “laches,” an equitable defense.  This means that while Edgerton is legally infringing Boss’s trademark, it would be unfair to enforce the law against them.  The person invoking laches (Edgerton) is asserting that the opposing party (Boss) has “slept on its rights”, and that, as a result of this delay, that other party is no longer entitled to its original claim.  3 years might be too long to wait and try to enforce your trademark rights…30 years is definitely too long.

port-a-pit3

port-a-pit2

port-a-pit1

Courtesy of Willamette Law Online

Indiana Patent Litigation Update

09 Monday Feb 2009

Posted by Kenan Farrell in Litigation, Patent

≈ Leave a comment

Tags

Alcon Research, Infringement of U.S. Patent

Alcon Research, Ltd. et al. v. Apotex Inc. et al.
1:09-cv-00102; filed February 2, 2009 in the Southern District of Indiana

Infringement of U.S. Patent Nos. 5,641,805 (“Topical Ophthalmic Formulations for Treating Allergic Eye Diseases,” issued June 24, 1997), 6,995,186 (“Olopatadine Formulations for Topical Administration,” issued on February 7, 2006), and 7,402,609 (same title, issued July 22, 2008 ) following a Paragraph IV certification as part of Apotex’s filing of an ANDA to manufacture a generic version of Alcon’s Pataday® (olopatadine hydrochloride ophthalmic solution, used to treat ocular itching associated with allergic conjunctivitis).  View the complaint here.

Alcon Research, Ltd. et al. v. Sandoz Inc.
1:09-cv-00103; filed February 2, 2009 in the Southern District of Indiana

Infringement of U.S. Patent Nos. 5,641,805 (“Topical Ophthalmic Formulations for Treating Allergic Eye Diseases,” issued June 24, 1997) following a Paragraph IV certification as part of Sandoz’s filing of an ANDA to manufacture a generic version of Alcon’s Patanol® (olopatadine hydrochloride ophthalmic solution, used to treat ocular itching associated with allergic conjunctivitis).  View the complaint here.

Courtesy of Patent Docs.

Horseshoe Casino prevails in trademark suit in Southern District

07 Saturday Feb 2009

Posted by Kenan Farrell in Litigation, Trademark

≈ Leave a comment

Tags

Indiana, Trademark

The Indiana Law Blog has a post up on a trademark decision in the Southern District of Indiana.  Click here for their full analysis.

“A federal judge has ruled that a New Albany strip club’s use of the name II Horseshoes and a golden horseshoe logo amounts to trademark infringement on nearby Horseshoe Casino.

U.S. District Judge Sarah Evans Barker signed a consent judgment and issued a permanent injunction this week ordering John Mattingly, the owner of II Horseshoes Gentleman’s Club on Old River Road, to stop any use of the Horseshoe name or its trademarked golden horseshoe.

The court also ordered Mattingly to remove the image from any advertising and promotional material, including signs, banners, cocktail napkins, clothing, business cards and receipts.”

Horseshoe Application

The Horseshoe Casino/Hotel trademarks (Reg. Nos. 1839688, 2370824; App. No.  77/657,333) are owned and managed by Harrah’s License Company.

For those not familiar with Indiana gaming law, apparently casinos can’t be on dry land, hence the silliness (pictured below) of putting the casino in a puddle of water and calling it a riverboat.

The Horseshoe Casino, by the way, is hosting a satellite tournament on Feb. 29 that could earn you a seat at the 2009 World Series of Poker Main Event in Las Vegas.  Good luck!

Horseshoe Casino

Indiana Patent Litigation Update

05 Thursday Feb 2009

Posted by Kenan Farrell in Litigation, Patent

≈ Leave a comment

Eli Lilly & Co. v. Invagen Pharmaceuticals, Inc.
1:09-cv-00087; filed January 28, 2009 in the Southern District of Indiana

Infringement of U.S. Patent Nos. 6,458,811 (“Benzothiophenes Formulations Containing Same and Methods,” issued October 1, 2002), 6,797,719 (same title, issued September 28, 2004), and 6,894,064 (same title, issued May 17, 2005) following a Paragraph IV certification as part of Invagen’s filing of an ANDA to manufacture a generic version of Lilly’s Evista® (raloxifene, used for the prevention and treatment of osteoporosis in postmenopausal women and for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk of invasive breast cancer).  View the complaint here.

Courtesy of Patent Docs

Newer posts →

Categories

  • Advertising Law (1)
  • Artists (23)
  • Authors (20)
  • Bloggers (37)
  • Branding (29)
  • Business Law (9)
  • Copyright (327)
  • Dear KLF Legal (4)
  • Defamation (5)
  • Entertainment Law (14)
  • Estate Law (2)
  • Family Law (2)
  • Fashion (5)
  • Federal Initiatives (33)
  • Indiana (603)
  • Indianapolis (51)
  • Intellectual Property (662)
  • Just for Fun (25)
  • KLF Legal (19)
  • Legislation (34)
  • Litigation (595)
  • Musicians (13)
  • Nonprofit (6)
  • Northern District of Indiana (215)
  • Patent (44)
  • Privacy (15)
  • Right of Publicity (8)
  • Social Media (56)
  • Southern District of Indiana (369)
  • Stories from the Week that Was (42)
  • Supreme Court (13)
  • Tech Developments (119)
  • Trade Dress (26)
  • Trade Secret (15)
  • Trademark (363)
  • What I'm Reading (8)

Bloggers Copyright Federal Initiatives Indiana Indianapolis Intellectual Property Legislation Litigation Northern District of Indiana Patent Social Media Southern District of Indiana Stories from the Week that Was Tech Developments Trademark

Blog at WordPress.com.

  • Subscribe Subscribed
    • Indiana Intellectual Property Blog
    • Join 81 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Indiana Intellectual Property Blog
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...